Haemonetics Total Assets 2010-2024 | HAE

Haemonetics total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
Haemonetics Annual Total Assets
(Millions of US $)
2024 $2,196
2023 $1,935
2022 $1,860
2021 $1,820
2020 $1,267
2019 $1,275
2018 $1,237
2017 $1,239
2016 $1,319
2015 $1,485
2014 $1,514
2013 $1,462
2012 $911
2011 $833
2010 $761
2009 $650
Haemonetics Quarterly Total Assets
(Millions of US $)
2024-09-30 $2,525
2024-06-30 $2,541
2024-03-31 $2,196
2023-12-31 $2,200
2023-09-30 $2,011
2023-06-30 $1,962
2023-03-31 $1,935
2022-12-31 $1,878
2022-09-30 $1,865
2022-06-30 $1,821
2022-03-31 $1,860
2021-12-31 $1,831
2021-09-30 $1,801
2021-06-30 $1,794
2021-03-31 $1,820
2020-12-31 $1,318
2020-09-30 $1,418
2020-06-30 $1,433
2020-03-31 $1,267
2019-12-31 $1,238
2019-09-30 $1,191
2019-06-30 $1,260
2019-03-31 $1,275
2018-12-31 $1,228
2018-09-30 $1,266
2018-06-30 $1,241
2018-03-31 $1,237
2017-12-31 $1,312
2017-09-30 $1,271
2017-06-30 $1,251
2017-03-31 $1,239
2016-12-31 $1,306
2016-09-30 $1,335
2016-06-30 $1,317
2016-03-31 $1,319
2015-12-31 $1,336
2015-09-30 $1,419
2015-06-30 $1,427
2015-03-31 $1,485
2014-12-31 $1,474
2014-09-30 $1,475
2014-06-30 $1,477
2014-03-31 $1,514
2013-12-31 $1,488
2013-09-30 $1,484
2013-06-30 $1,480
2013-03-31 $1,462
2012-12-31 $1,474
2012-09-30 $1,455
2012-06-30 $928
2012-03-31 $911
2011-12-31 $848
2011-09-30 $824
2011-06-30 $853
2011-03-31 $833
2010-12-31 $783
2010-09-30 $738
2010-06-30 $698
2010-03-31 $761
2009-12-31 $702
2009-09-30 $714
2009-06-30 $692
2009-03-31 $650
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.862B $1.309B
Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $194.987B 24.87
Stryker (SYK) United States $136.147B 30.68
Boston Scientific (BSX) United States $130.670B 37.57
EssilorLuxottica (ESLOY) France $110.026B 0.00
Medtronic (MDT) Ireland $102.570B 15.24
Haleon (HLN) United Kingdom $43.909B 28.53
Lonza Group Ag (LZAGY) Switzerland $42.293B 0.00
GE HealthCare Technologies (GEHC) United States $35.376B 18.35
ResMed (RMD) United States $33.995B 27.93
Terumo (TRUMY) Japan $28.800B 40.67
Koninklijke Philips (PHG) Netherlands $23.527B 18.01
Zimmer Biomet Holdings (ZBH) United States $21.064B 13.41
Insulet (PODD) United States $17.996B 71.67
Baxter (BAX) United States $14.756B 9.60
Smith & Nephew SNATS (SNN) United Kingdom $10.838B 0.00
BellRing Brands (BRBR) United States $10.021B 40.32
Bio-Rad Laboratories (BIO) United States $9.125B 31.01
Demant (WILYY) Denmark $7.926B 0.00
Lantheus Holdings (LNTH) United States $6.392B 14.85
Prestige Consumer Healthcare (PBH) United States $3.886B 19.33
ICU Medical (ICUI) United States $3.751B 35.71
Perrigo (PRGO) Ireland $3.510B 10.33
Envista Holdings (NVST) United States $3.103B 23.11
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
QuidelOrtho (QDEL) United States $2.894B 18.63
GN Store Nord (GNNDY) Denmark $2.864B 18.36
Neogen (NEOG) United States $2.605B 30.05
LeMaitre Vascular (LMAT) United States $2.074B 50.41
Green Thumb Industries (GTBIF) United States $1.630B 28.52
AtriCure (ATRC) United States $1.465B 0.00
InMode (INMD) Israel $1.444B 8.68
Maravai LifeSciences Holdings (MRVI) United States $1.371B 0.00
AdaptHealth (AHCO) United States $1.304B 9.32
BioLife Solutions (BLFS) United States $1.211B 0.00
Owens & Minor (OMI) United States $0.973B 7.60
CeriBell (CBLL) United States $0.958B 0.00
Curaleaf Holdings (CURLF) Canada $0.955B 0.00
Phibro Animal Health (PAHC) United States $0.883B 15.58
Evolus (EOLS) United States $0.688B 0.00
Omeros (OMER) United States $0.593B 0.00
VAREX IMAGING (VREX) United States $0.593B 26.15
Capricor Therapeutics (CAPR) United States $0.587B 0.00
Surmodics (SRDX) United States $0.572B 0.00
Verano Holdings (VRNOF) United States $0.445B 0.00
Cresco Labs (CRLBF) United States $0.429B 0.00
Quanterix (QTRX) United States $0.383B 0.00
ZimVie (ZIMV) United States $0.373B 31.44
Valneva SE (VALN) France $0.353B 0.00
Biote (BTMD) United States $0.313B 6.86
Viemed Healthcare (VMD) United States $0.312B 29.70
Canopy Growth (CGC) Canada $0.295B 0.00
Cerus (CERS) United States $0.293B 0.00
OraSure Technologies (OSUR) United States $0.283B 18.95
Sanara MedTech (SMTI) United States $0.276B 0.00
Zynex (ZYXI) United States $0.268B 56.00
High Tide (HITI) Canada $0.237B 98.00
Aurora Cannabis (ACB) Canada $0.225B 0.00
Utah Medical Products (UTMD) United States $0.211B 14.54
MacroGenics (MGNX) United States $0.200B 0.00
Sanuwave Health (SNWV) United States $0.188B 2.64
Organigram Holdings (OGI) Canada $0.184B 0.00
TerrAscend (TSNDF) Canada $0.181B 0.00
Brainsway (BWAY) Israel $0.169B 89.60
FitLife Brands (FTLF) United States $0.151B 19.04
Jin Medical (ZJYL) China $0.132B 0.00
TriSalus Life Sciences (TLSI) United States $0.110B 0.00
Quipt Home Medical (QIPT) United States $0.104B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.100B 0.00
Fonar (FONR) United States $0.096B 10.79
Veru (VERU) United States $0.092B 0.00
Exagen (XGN) United States $0.083B 0.00
Rockwell Medical (RMTI) United States $0.066B 34.17
InterCure (INCR) Israel $0.061B 0.00
Apyx Medical (APYX) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Modular Medical (MODD) United States $0.050B 0.00
Cytosorbents (CTSO) United States $0.048B 0.00
Safety Shot (SHOT) United States $0.042B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
Nephros (NEPH) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Innovative Eyewear (LUCY) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Trinity Biotech (TRIB) Ireland $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Agape ATP (ATPC) $0.005B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Sharps Technology (STSS) United States $0.003B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 12.82
SNDL (SNDL) Canada $0.000B 0.00